Greece - RECs and Medical Research
History
The first REC in Greece was established in 1965 at the Institute of Child Health and legislation was passed in 1973. The Legislative Decree 97/1973 concerned approval of clinical drug research and was followed in 1978 by a Ministerial Circular (A2/oik3061/5.6.1978) which imposed the establishment of RECs at a local level.
A National Council of Medical Ethics & Deontology was established in the early 90s (Law 2071/1992) whose main objectives included participation in the forming of policy of the Ministry of Health & Welfare, handing down opinions on medical ethics, consultation to settle disagreements in RECs and the establishment of a Centre of Medical Ethics.
A National Bioethics Commission was established by Law 2667/1998 which investigates ethical implications and provides recommendations on policy.
There is a new National Committee of Deontology of Clinical Trials which will shortly be responsible for final approval of research projects. The ministerial decision providing for the by-laws regarding this committee was enacted on May 1st, 2004.
Summary of Greek RECs
| Type of REC | National Committe of Deontology of Clinical Trials | Regional | Local |
| Where situated? | National Organisation for Medicines (EOF) | Governing Board of Regional health service | Hospital/Clinic |
| Who applies to them? | Regional RECs | Researchers, after approval locally | researchers |
| Formal/Informal | Formal | Formal | Formal |
| National/Regional | National | Regional | Local |
| Laws Involved |
|
|
|
| Guidance Involved | |||
| Membership requirements |
6 members, including a lawyer, a theologian, a scientist & health science professionals |
- | 5 members |
| Responsible/accountable to whom? | Ministry of Health | - | - |
| Approval or Advisory powers | Approval | Advisory, although approval is necessary | Advisory, although approval is necessary |
Not submitting research or failing to follow review
Ethical approval is necessary for the research to go ahead and also for publication.
Which body, if not the REC itself takes this action, and how do they proceed?
Impact of Directive 2001/20 EC
This directive has been incorporated into Greek Law through Ministerial Decision DYC3/89292 and State Journal B' 1973/31.12.2003. For the first time a control mechanism of the ‘ethical appropriateness’ of a clinical trial is established through the 'National Committee of Deontology of Clinical Trials'. It is vested with decisive powers in deciding whether to permit research projects to go ahead.
Legal action that can be taken against RECs
Any person whose legal interest can be affected by a decision of an REC can bring an action against that committee. The courts would carry out an evaluation of harm.
Links section
- Greek law
- Ministry of Health & Welfare (in English & Greek)
- National Bioethics Commission (in English & Greek)
- National Organisation for Medicines (in English & Greek)
- Garanis-Papadatos, T. and Dalla Vorgia, P. ‘Clinical trials in Greece: ethical review proceedings’ (2000) 7 European Journal of Health Law 441–447.
See the REC bibliography section for more links and papers
